Status:
COMPLETED
Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Testcenter Danmark, Statens Serum Institut
Copenhagen Emergency Medical Services
Conditions:
Covid19
Rapid Antigen Test
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project aims to investigate the sensitivity and specificity of the rapid antigen test compared to RT-PCR test performed on samples from the nasopharynx and the anterior nasal cavity and the oroph...
Detailed Description
The purpose of the study is to investigate the sensitivity and specificity of correct SARS-CoV-2 test results of nasopharyngeal swabs and swabs swabs from the anterior part of the nose examined by rap...
Eligibility Criteria
Inclusion
- Age \> 18 years
- A booked appointment for a COVID-19 test at one of Testcenter Denmark's test centers in the Capital Region
Exclusion
- Previously tested positive for COVID-19
- Non-fluent in Danish
Key Trial Info
Start Date :
December 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2021
Estimated Enrollment :
4697 Patients enrolled
Trial Details
Trial ID
NCT04689399
Start Date
December 26 2020
End Date
March 25 2021
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christian von Buchwald, MD, DMSc, Professor
Copenhagen, Denmark, 2100